About DRONCIT INJECTABLE

DRONCIT INJECTABLE is a prescription medication containing the active ingredient Praziquantel, used to treat schistosomiasis, a parasitic infection caused by Schistosoma species. It is administered via intramuscular injection and works by killing the parasites in the body.

Key Benefits & Uses

Treatment of schistosomiasis caused by Schistosoma mansoni, S. haematobium, and S. japonicum.
Effective against adult and juvenile stages of the parasite.
May be used in combination with other medications for enhanced efficacy.

Active Ingredient & Action

Praziquantel, the active ingredient in DRONCIT INJECTABLE, works by binding to the parasite's calcium channels, leading to an influx of calcium ions and ultimately causing the parasite's death. This mechanism of action is specific to the parasite and does not affect the host's cells.

Important Notes

DRONCIT INJECTABLE should only be used under the guidance of a qualified healthcare professional. It is essential to follow the recommended dosage and administration schedule to ensure optimal efficacy and minimize the risk of side effects. Patients with certain medical conditions or taking other medications may require special precautions or dose adjustments.